We are live on
!
Find out more
EP
Eversept Partners Portfolio holdings
AUM
$1.52B
1-Year Est. Return
121.13%
This Fund
S&P 500
1 Year Est. Return
+121.13%
AUM
$1.52B
AUM Growth
-$266M
(-15%)
Holding
147
Top Buys
| 1 | +$44.7M | |
| 2 | +$35.8M | |
| 3 | +$33.9M | |
| 4 |
ABVX
Abivax
ABVX
|
+$32.7M |
| 5 |
Omega Healthcare
OHI
|
+$26.7M |
Top Sells
| 1 | +$48.5M | |
| 2 | +$42.6M | |
| 3 | +$38.7M | |
| 4 |
Viridian Therapeutics
VRDN
|
+$31.7M |
| 5 |
Bruker
BRKR
|
+$27.9M |
Sector Composition
| 1 | Healthcare | 92.92% |
| 2 | Real Estate | 6.98% |
| 3 | Financials | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Repligen
RGEN
$7.34B
| $14.2M | 0.94% |
+120,785
|
|
||
|
BBNX
27
Beta Bionics
BBNX
$641M
| $14.2M | 0.93% |
1,414,838
+736,576
|
|
||
|
28
Viridian Therapeutics
VRDN
$1.8B
| $14M | 0.92% |
713,269
-1,068,966
|
|
||
29
Arcutis Biotherapeutics
ARQT
$2.85B
| $13.6M | 0.9% |
576,580
+141,946
|
|
||
30
Ardelyx
ARDX
$1.38B
| $13.4M | 0.88% |
2,229,446
+514,317
|
|
||
|
LTC
31
LTC Properties
LTC
$1.87B
| $11.9M | 0.79% |
+321,046
|
|
||
32
BioMarin Pharmaceuticals
BMRN
$11.2B
| $11.7M | 0.77% |
207,768
+114,020
|
|
||
33
Chemed
CHE
$5.92B
| $11.7M | 0.77% |
+31,057
|
|
||
34
Pharvaris
PHVS
$2.21B
| $11.5M | 0.76% |
406,960
-32,217
|
|
||
35
Pennant Group
PNTG
$1.14B
| $9.52M | 0.63% |
312,178
+18,218
|
|
||
36
NewAmsterdam Pharma
NAMS
$3.55B
| $9.15M | 0.6% |
285,764
-135,063
|
|
||
37
Palisade Bio
PALI
$294M
| $8.73M | 0.58% |
4,987,499
-404,049
|
|
||
38
Moderna
MRNA
$18.9B
| $8.11M | 0.53% |
159,708
-108,115
|
|
||
39
Viking Therapeutics
VKTX
$3.39B
| $7.78M | 0.51% |
+239,110
|
|
||
40
Icon
ICLR
$11.6B
| $7.6M | 0.5% |
68,688
-27,144
|
|
||
41
Xenon Pharmaceuticals
XENE
$5.1B
| $7.53M | 0.5% |
129,574
-101,806
|
|
||
42
Revvity
RVTY
$11.6B
| $7.43M | 0.49% |
84,854
-77,923
|
|
||
43
Agios Pharmaceuticals
AGIO
$1.67B
| $6.77M | 0.45% |
+200,000
|
|
||
44
Structure Therapeutics
GPCR
$2.93B
| $6.65M | 0.44% |
138,036
+10,475
|
|
||
45
Bio-Techne
TECH
$8.52B
| $6.58M | 0.43% |
125,896
-251,509
|
|
||
46
Glaukos
GKOS
$7.42B
| $6.48M | 0.43% |
60,214
-87,257
|
|
||
47
Tenet Healthcare
THC
$14.3B
| $5.57M | 0.37% |
+29,512
|
|
||
48
Madrigal Pharmaceuticals
MDGL
$11B
| $5.23M | 0.35% |
+10,000
|
|
||
49
Intuitive Surgical
ISRG
$151B
| $5.13M | 0.34% |
11,119
-6,943
|
|
||
50
Esperion Therapeutics
ESPR
$809M
| $4.76M | 0.31% |
1,735,963
-2,115,170
|
|